On the evening of October 22, 2021, the launch conference of Aibo Intelligent Children's rehabilitation series products was held in the beautiful "River City" Wuhan. The theme of this conference is "Technology empowerment, Building a future of children's rehabilitation".
Professor Xu Xiaoyan of the First Affiliated Hospital of Anhui Medical University explained the solution of Aibo Intelligence on children's rehabilitation from the aspects of early diagnosis of diseases, rehabilitation AIDS and family follow-up: Solve the difficult problem of primary medical diagnosis through intelligent medical assistants. At a time when traditional rehabilitation products are facing upgrading demands, Aibo Intelligence is committed to systemizing AI to enable rehabilitation, and has self-developed a series of products that meet the needs of posture management (sitting and standing), such as Akerib TM children's standing frame and Akerbe TM children's customized cushion; At the same time, for travel training and improve the ability of daily life, we have developed AiKEqi TM children's outdoor tricycle and children's lower limb exoskeleton robot. Using AI technology through the post-diagnosis management platform, real-time feedback of the patient's muscle strength, muscle tension, gait and other data, based on these data, the rehabilitator can track the patient in real time and adjust the appropriate rehabilitation plan. In the future, Aibo Intelligent will further combine the advantages of iFLYtek artificial intelligence technology, further intelligent rehabilitation products, and help the research and development and promotion of rehabilitation assistance robots.
At the meeting, Xie Xinzhen, vice president of iFlytek, introduced the mission and vision of Aibo Intelligent, and shared the innovation and application of Aibo intelligent child rehabilitation series products
During the meeting, Professor Xiao Nong, head of the rehabilitation Medicine Group of the Pediatric Branch of the Chinese Medical Association, recognized and affirmed the combination of Aibo Intelligence and IFLYtek artificial intelligence technology to focus on rehabilitation products and help Chinese children's rehabilitation with scientific and technological advantages. Professor Xu Kaishou, deputy head of the rehabilitation group of the Pediatrics Branch of the Chinese Medical Association, said that IFFY, as an industry leader in AI artificial intelligence, believes that it will be able to better develop the children's rehabilitation AIDS industry in the future, but hopes that more clinical evidence can be added in the future research and development process to make more products suitable for children's needs.